Related Experiment Video
Updated: Jul 16, 2026

Simultaneous Detection of Different Antibody Classes in a Multiplexed Serological Test
Published on: July 14, 2023
PathogenMip assay: a multiplex pathogen detection assay
Michael S Akhras1, Sreedevi Thiyagarajan, Andrea C Villablanca
1Stanford Genome Technology Center, Stanford University, Palo Alto, California, United States of America.
Abstract:
The Molecular Inversion Probe (MIP) assay has been previously applied to a large-scale human SNP detection. Here we describe the PathogenMip Assay, a complete protocol for probe production and applied approaches to pathogen detection. We have demonstrated the utility of this assay with an initial set of 24 probes targeting the most clinically relevant HPV genotypes associated with cervical cancer progression. Probe construction was based on a novel, cost-effective, ligase-based protocol. The assay was validated by performing pyrosequencing and Microarray chip detection in parallel experiments. HPV plasmids were used to validate sensitivity and selectivity of the assay. In addition, 20 genomic DNA extracts from primary tumors were genotyped with the PathogenMip Assay results and were in 100% agreement with conventional sequencing using an L1-based HPV genotyping protocol. The PathogenMip Assay is a widely accessible protocol for producing and using highly discriminating probes, with experimentally validated results in pathogen genotyping, which could potentially be applied to the detection and characterization of any microbe.
Insights
The novel PathogenMip Assay offers a cost-effective method for pathogen detection using highly discriminating probes. This assay accurately genotypes human papillomavirus (HPV), showing potential for broad microbial identification.
Area of Science:
- Molecular Biology
- Microbiology
- Genetics
Background:
- The Molecular Inversion Probe (MIP) assay is established for human SNP detection.
- Pathogen detection requires precise and accessible genotyping methods.
Purpose of the Study:
- To introduce the PathogenMip Assay, a comprehensive protocol for pathogen detection.
- To develop a cost-effective method for producing highly discriminating probes for genotyping.
Main Methods:
- Developed a novel, ligase-based protocol for probe production.
- Targeted 24 human papillomavirus (HPV) genotypes associated with cervical cancer.
- Validated the assay using pyrosequencing, microarray detection, and conventional sequencing.
Main Results:
- Achieved 100% agreement with conventional sequencing for HPV genotyping in tumor DNA.
- Demonstrated high sensitivity and selectivity using HPV plasmids.
- Successfully genotyped clinically relevant HPV genotypes.
Conclusions:
- The PathogenMip Assay provides a widely accessible protocol for pathogen genotyping.
- The assay is experimentally validated and shows potential for detecting and characterizing diverse microbes.
Related Concept Videos
Rapid Identification of Pathogens
Automated Microbial Diagnostics
